Depression Research Unit
The Depression Research Unit, under the direction of Jay D. Amsterdam, MD, focuses on severe and refractory depression. During the course of over 20 years, the DRU has conducted more than 100 treatment outcome studies, including more than 70 phase II-IV pivotal drug trials with antidepressants, anxiolytics, and mood stabilizers. In recent years, the DRU has received significant NIH research funding, as well as pharmaceutical industry grants and funding from the Stanley Research Foundation.
The DRU studies depression and bipolar disorder from many different perspectives in order to better understand and treat these illnesses. Various treatment options are available to research participants at no cost.
Please call 1-866-301-4PBH to discuss or schedule treatment.
|